Literature DB >> 12763063

Involvement of cholinergic and gabaergic systems in the fragile X knockout mice.

M D'Antuono1, D Merlo, M Avoli.   

Abstract

Fragile X syndrome is an inherited cause of mental retardation. We used extra- and intracellular recordings in brain slices obtained from wild type and fragile X knockout mice to establish whether bath application of the cholinergic agent carbachol (5 microM) induces different responses in neurons of the subiculum, a limbic structure involved in learning and memory. We found that carbachol diminished excitatory post-synaptic responses induced by CA1 stratum radiatum stimulation in wild type mice, but caused an unexpected increase in knockout animals. Moreover, these responses augmented in knockout mice after carbachol washout, a phenomenon that resembled the muscarinic long-term potentiation seen in wild type mice during application of carbachol and GABA(A) receptor antagonists. We also used paired-pulse stimulation to determine whether the changes in synaptic excitability induced by carbachol were caused by pre- or post-synaptic mechanism. Under control conditions, this protocol induced facilitation in both wild type and knockout mice; in contrast, during carbachol application, this facilitatory effect was seen in wild type mice only. In conclusion, our data highlight for the first time differences in cholinergic and GABA-ergic mechanisms that may contribute to the phenotype of fragile X patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763063     DOI: 10.1016/s0306-4522(03)00103-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  28 in total

Review 1.  The contribution of GABAergic dysfunction to neurodevelopmental disorders.

Authors:  Kartik Ramamoorthi; Yingxi Lin
Journal:  Trends Mol Med       Date:  2011-04-21       Impact factor: 11.951

Review 2.  Potential therapeutic interventions for fragile X syndrome.

Authors:  Josien Levenga; Femke M S de Vrij; Ben A Oostra; Rob Willemsen
Journal:  Trends Mol Med       Date:  2010-09-21       Impact factor: 11.951

3.  The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide.

Authors:  Surabi Veeraragavan; Nghiem Bui; Jennie R Perkins; Lisa A Yuva-Paylor; Richard Paylor
Journal:  Behav Neurosci       Date:  2011-10       Impact factor: 1.912

4.  Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome.

Authors:  Surabi Veeraragavan; Nghiem Bui; Jennie R Perkins; Lisa A Yuva-Paylor; Randall L Carpenter; Richard Paylor
Journal:  Psychopharmacology (Berl)       Date:  2011-04-13       Impact factor: 4.530

5.  Regulation of GABAA receptors by fragile X mental retardation protein.

Authors:  Baosong Liu; Lijun Li; Juan Chen; Zefen Wang; Zhiqiang Li; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-09-10

6.  Cholinergic dysfunction in fragile X syndrome and potential intervention: a preliminary 1H MRS study.

Authors:  Shelli R Kesler; Amy A Lightbody; Allan L Reiss
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

7.  Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.

Authors:  Randi Hagerman; Gry Hoem; Paul Hagerman
Journal:  Mol Autism       Date:  2010-09-21       Impact factor: 7.509

8.  Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

Authors:  Giulia Curia; Thomas Papouin; Philippe Séguéla; Massimo Avoli
Journal:  Cereb Cortex       Date:  2008-09-11       Impact factor: 5.357

9.  Prepulse inhibition in fragile X syndrome: feasibility, reliability, and implications for treatment.

Authors:  David Hessl; Elizabeth Berry-Kravis; Lisa Cordeiro; Jennifer Yuhas; Edward M Ornitz; Aaron Campbell; Elizabeth Chruscinski; Crystal Hervey; James M Long; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

10.  Temporal requirements of the fragile x mental retardation protein in modulating circadian clock circuit synaptic architecture.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Front Neural Circuits       Date:  2009-08-20       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.